Current grants include:


2018-2019 Foundation for Polish Science TEAM TECH Core Facility Plus/2017-2/2: "Flow-PROSPER – Flow Cytometry Protein Signature Platform for Personalised Therapies" (PI - Katarzyna Piwocka) - see Flow-PROSPER

2018-2019 Leukemia Research Foundation New Investigator grant:  "Synthetic lethality in leukemia - effect of PARP1 inhibitors in humanized bone marrow niche" (PI - Paulina Podszywalow-Bartnicka)

2018-2019 National Science Centre (NCN) PRELUDIUM: "Role of the intercellular exchange of vesicles and proteins to modulate biological functions of leukemia cells by the stroma" (PI - Marta Kolba)

2017-2019 National Science Centre (NCN) PRELUDIUM: "Role of FMRP protein in regulation of BRCA1 translation in leukemia cells" (PI - Magdalena Wolczyk)

2016-2018 National Science Centre (NCN) PRELUDIUM: "Phosphorylation of translation initiation factor eIF2alpha as regulator of synthesis of proinflammatory and signaling cytokines in leukemia cells; role in autocrine activation of JAK/STAT pathways and therapy resistance" (PI -Wioleta Dudka-Ruszkowska)

2014-2018  National Science Centre (NCN) SONATA BIS : The influence of PERK-eIF2alpha pathway on the leukemia microenvironment; the role of cell-cell interactions and composition of exosomal miRNAs"  (PI - Katarzyna Piwocka)

2015-2018 National Science Centre (NCN) SONATA: "The influence of bone marrow microenvironment on the regulation of BRCA1 mRNA translation in leukemia cells; role in the cells invasiveness and therapy resistance" (PI - Paulina Podszywalow-Bartnicka)

2015-2020 –EU Horyzon 2020, Maria Curie COFUND grant Bio4Med: Biology for Medicine International PhD Programme; Project title: "Precision medicine-guided synthetic lethality to eradicate quiescent and proliferating leukemia stem cells: molecular mechanisms and therapeutic appications"


2011-2014 National Science Centre (NCN) OPUS: "Linking stress response with genomic instability in chronic myeloid leukaemia cells; role of the PERK-eIF2α phosphorylation pathway in the regulation of BRCA1 translation, mitosis and disease progression" (PI - Katarzyna Piwocka)

2011-2014 National Science Centre (NCN) PRELUDIUM: The role of the PERK-eIF2a pathway in the survival and cancerogenic potential of Bcr-Abl expressing cells  - in vivo studies"  (PI - MOnika Kusio-Kobialka)

2011-2014 European Union's the 7th Framework Programme, BIO-IMAGINE grant; Project title: Bio-imaging in research innovation and education. WP5: Instrumentation

2010-2013  Ministry of Science and Higher Education: "Role of adaptative response to ER stress and the PERK-eIF2alpha pathway in survival and therapy resistance of BCR-ABL-expressing cells" (PI - Katarzyna Piwocka)